Healthcare Industry News: colonoscopy
News Release - January 5, 2011
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in BrazilSTOUGHTON, Mass., Jan. 5, 2011 -- (Healthcare Sales & Marketing Network) -- SyncMedical LLC today announced that the Brazilian ANVISA (Agencia Nacional de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) has approved their Ethos Spine Pedicle Screw System for sale in Brazil. SyncMedical's Ethos Spine product line was developed to fulfill the need for quality and cost effective treatment solutions to surgeons in the ever-growing, ever-changing field of spine surgery. The Ethos Spine product line provides U.S. manufactured minimally invasive solutions to fit the needs of the global medical community. Ethos product offerings include the Ethos C-Spacer, the Ethos PEEK VBR System and the above mentioned Ethos Pedicle Screw System.
Earlier this month SyncMedical also received ANVISA approval for the Spirus Medical Endo-Ease Discovery System. SyncMedical is the exclusive Latin American distributor for Spirus Medical, Inc. a core product line of SyncMedical's Internal Medicine Division.
Spirus Medical, Inc. is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component.
SyncMedical LLC is an affiliated company of STD Med, Inc. SyncMedical develops, produces and markets medical devices exclusively for regions outside of the United States by leveraging its strategic partnerships with industry leaders and medical professionals. SyncMedical is focused on developing access to the next generation of medical innovations. Our product development partners and our global team of representatives work together at every stage to provide solutions for the international medical community.
STD Med, Inc.
STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc., Spirus Medical, Inc. and Cardiosolutions, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.